US 12,431,230 B2
Interconnection of drug administration systems
Gregory J. Bakos, Mason, OH (US); Michael A. Baratta, West Chester, PA (US); Yueheng Dou, Fall River, MA (US); Jason L. Harris, Lebanon, OH (US); Emma Louise Hubert, San Jose, CA (US); Monica A. Kapil, San Jose, CA (US); Peter Krulevitch, Milpitas, CA (US); Wouter Jacques Noel Lequieu, Lievegem (BE); Dolores Perez, Eaton, PA (US); Whitney Phillips, Camas, WA (US); Frederick E. Shelton, Cincinnati, OH (US); and Hong Yan, Livermore, CA (US)
Assigned to JANSSEN PHARMACEUTICALS, INC., Titusville, NJ (US)
Appl. No. 17/763,085
Filed by JANSSEN PHARMACEUTICALS, INC., Titusville, NJ (US)
PCT Filed Sep. 24, 2020, PCT No. PCT/IB2020/058966
§ 371(c)(1), (2) Date Mar. 23, 2022,
PCT Pub. No. WO2021/059210, PCT Pub. Date Apr. 1, 2021.
Claims priority of provisional application 62/905,441, filed on Sep. 25, 2019.
Claims priority of provisional application 62/905,442, filed on Sep. 25, 2019.
Claims priority of provisional application 62/905,443, filed on Sep. 25, 2019.
Claims priority of provisional application 62/905,445, filed on Sep. 25, 2019.
Claims priority of provisional application 63/020,928, filed on May 6, 2020.
Prior Publication US 2022/0336074 A1, Oct. 20, 2022
Int. Cl. G16H 20/13 (2018.01); G16H 20/17 (2018.01); H04L 9/40 (2022.01); H04W 12/037 (2021.01)
CPC G16H 20/13 (2018.01) [G16H 20/17 (2018.01); H04L 63/0421 (2013.01); H04W 12/037 (2021.01)] 25 Claims
OG exemplary drawing
 
1. A drug administration device configured to retain a drug therein, comprising:
a sensor configured to sense information relating to at least one of the drug administration device and the drug;
a memory configured to store data therein, the stored data including a key and an algorithm including at least one variable parameter, wherein the key is established with a remotely located server, is unique to the drug administration device and the remotely located server, and uniquely identifies a patient associated with the drug administration device;
a communications interface configured to wirelessly transmit data indicative of the sensed information to a remotely located communications interface without any identifying patient information and to wirelessly receive data from the remotely located communications interface; and
a processor configured to use the key to anonymize the data indicative of the sensed information prior to the transmission of the data indicative of the sensed information such that the data does not include any identifying patient information, use the key in decrypting the data received from the remotely located communications interface, use the algorithm in controlling delivery of the drug from the drug administration device to a patient, and to change the at least one variable parameter of the algorithm stored in the memory based on the data received from the remotely located communications interface.